Barclays PLC lifted its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 62,563 shares of the company's stock after purchasing an additional 19,093 shares during the quarter. Barclays PLC owned about 0.35% of Addus HomeCare worth $7,842,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of ADUS. Summit Place Financial Advisors LLC grew its position in shares of Addus HomeCare by 0.9% in the 4th quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company's stock valued at $1,180,000 after buying an additional 80 shares during the last quarter. Janney Montgomery Scott LLC lifted its stake in shares of Addus HomeCare by 0.9% during the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after buying an additional 91 shares during the period. Alliancebernstein L.P. increased its stake in shares of Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock valued at $2,465,000 after acquiring an additional 91 shares during the last quarter. Parkside Financial Bank & Trust increased its stake in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in shares of Addus HomeCare by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,923 shares of the company's stock worth $742,000 after buying an additional 150 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ADUS has been the subject of a number of recent analyst reports. Oppenheimer increased their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. JMP Securities reaffirmed a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Tuesday, April 22nd. StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, Macquarie restated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. One analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $139.00.
Check Out Our Latest Stock Report on ADUS
Addus HomeCare Trading Down 0.3 %
Shares of NASDAQ:ADUS traded down $0.33 during trading on Tuesday, reaching $100.71. The company had a trading volume of 8,199 shares, compared to its average volume of 162,013. Addus HomeCare Co. has a 12 month low of $88.96 and a 12 month high of $136.72. The company has a fifty day moving average of $97.69 and a two-hundred day moving average of $115.78. The stock has a market capitalization of $1.83 billion, a P/E ratio of 22.97, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The company had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
